1 Min Read
Feb 13 (Reuters) -
* Marathon Pharmaceuticals Llc CEO says on CureDuchenne blog - pausing launch of EMFLAZA; says will maintain expanded access program Source text : bit.ly/2lDiGsN
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.